These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1487411)

  • 21. Phase II trial of Baker's antifol in metastatic sarcoma.
    Thigpen JT; O'Bryan RM; Benjamin RS; Coltman CA
    Cancer Treat Rep; 1977 Nov; 61(8):1485-7. PubMed ID: 922752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Jun; 10(3):237-9. PubMed ID: 3473924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of echinomycin in advanced soft tissue sarcomas. A Southwest Oncology Group study.
    Taylor SA; Metch B; Balcerzak SP; Hanson KH
    Invest New Drugs; 1990 Nov; 8(4):381-3. PubMed ID: 2084072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
    Zidar BL; Baker LH; Rivkin SE; Balcerzak SP; Stephens RL
    Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy of patients with advanced soft tissue sarcoma with use of DVA (vindesine sulfate), adriamycin and cyclophosphamide (DAC).
    Brenner J; Magill GB; Wissel P; Sordillo PP
    Cancer; 1983 Oct; 52(7):1142-5. PubMed ID: 6349786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.
    Le Cesne A; Blay JY; Domont J; Tresch-Bruneel E; Chevreau C; Bertucci F; Delcambre C; Saada-Bouzid E; Piperno-Neumann S; Bay JO; Mir O; Ray-Coquard I; Ryckewaert T; Valentin T; Isambert N; Italiano A; Clisant S; Penel N
    Lancet Oncol; 2015 Mar; 16(3):312-9. PubMed ID: 25680558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of merbarone (NSC 336628) in patients with advanced gastric carcinoma.
    Ajani JA; Winn R; Baez L; Pollock T; Maher T; Hallinan-Fueger B; Newman J
    Cancer Invest; 1994; 12(5):488-90. PubMed ID: 7922705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study.
    Chevallier B; Leyvraz S; Olivier JP; Fargeot P; Facchini T; Vo Van ML
    Cancer Invest; 1993; 11(2):135-9. PubMed ID: 8462014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of 10-EDAM in advanced soft tissue sarcoma. A study of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group.
    Knowling M; Bramwell V; Eisenhauer E; Boos G; Bodurtha A; Quirt I
    Ann Oncol; 1994 Oct; 5(8):766-8. PubMed ID: 7826912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of topotecan by continuous infusion in patients with advanced soft tissue sarcomas, a SWOG study. Southwest Oncology Group.
    Budd GT; Rankin C; Hutchins LF; Wong L; Petruska PJ; Antman K;
    Invest New Drugs; 2002 Feb; 20(1):129-32. PubMed ID: 12003189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.
    Zalupski M; Metch B; Balcerzak S; Fletcher WS; Chapman R; Bonnet JD; Weiss GR; Ryan J; Benjamin RS; Baker LH
    J Natl Cancer Inst; 1991 Jul; 83(13):926-32. PubMed ID: 2067035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.
    Saiki JH; Baker LH; Stephens RL; Fabian CJ; Kraut EH; Fletcher WS
    Cancer Treat Rep; 1982 Aug; 66(8):1673-4. PubMed ID: 7105060
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
    Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Leahy M; Ray-Coquard I; Verweij J; Le Cesne A; Duffaud F; Hogendoorn PC; Fowst C; de Balincourt C; di Paola ED; van Glabbeke M; Judson I; Blay JY;
    Eur J Cancer; 2007 Jan; 43(2):308-15. PubMed ID: 17095209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.
    Casper ES; Christman KL; Schwartz GK; Johnson B; Brennan MF; Bertino JR
    Cancer; 1993 Aug; 72(3):766-70. PubMed ID: 8392904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO).
    Schmitt T; Mayer-Steinacker R; Mayer F; Grünwald V; Schütte J; Hartmann JT; Kasper B; Hüsing J; Hajda J; Ottawa G; Mechtersheimer G; Mikus G; Burhenne J; Lehmann L; Heilig CE; Ho AD; Egerer G
    Eur J Cancer; 2016 Sep; 64():74-82. PubMed ID: 27367154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.
    Yovine A; Riofrio M; Blay JY; Brain E; Alexandre J; Kahatt C; Taamma A; Jimeno J; Martin C; Salhi Y; Cvitkovic E; Misset JL
    J Clin Oncol; 2004 Mar; 22(5):890-9. PubMed ID: 14990645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group.
    Mouridsen HT; Bramwell VH; Lacave J; Metz R; Vendrik C; Hild J; McCreanney J; Sylvester R
    Cancer Treat Rep; 1981; 65(5-6):509-11. PubMed ID: 6453646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group Study.
    Verweij J; Krzemieniecki K; Kok T; Poveda A; van Pottelsberghe C; van Glabbeke M; Mouridsen H
    Eur J Cancer; 1993; 29A(2):208-9. PubMed ID: 8422284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.